Michael Tellinger

Scientist, Author, Explorer, Humanitarian
Founder of the ONE SMALL TOWN initiative.
Discovered the vanished civilizations of Southern Africa

[Michael Tellinger @MichaelTelling2]

Discover the Hidden History of the world at Stone Circle Lodge. Perfect halfway stop to the Kruger Park from Joburg. See the largest concentration of ancient ruins, Adam's Calendar, tools and artefacts, advanced technology.
[email protected]

https://t.co/uZv3n54gUR

[Michael Tellinger @MichaelTelling2]

Theo Jansen is a worldly treasure.
Pure genius.

[Massimo @Rainmaker1973]

Animaris Rex is an 18-metre-long walking 'beach animal' propelled by the wind, created by Theo Jansen as a fusion of art and engineering.

[Michael Tellinger @MichaelTelling2]

South Africa is home to the largest concentration of ancient ruins on Earth. Two examples of Magnetron ruins. The ancients were generating huge amounts of energy. What were they using the energy for?
https://t.co/ZQBttymcpM
Keep exploring
Michael Tellinger

[Michael Tellinger @MichaelTelling2]

Join my Private Video channel https://t.co/0ZdSL44cJg
For hundreds of videos and real time discoveries.
https://t.co/QVHdrxOA84

[Michael Tellinger @MichaelTelling2]

One of my favourite fossilized body parts. Obvious even to an untrained eye. Some kind of tube, filled with some stuff - all turned to stone. Discovered among the stone circle ruins near Waterval Boven, Mpumalanga, South Africa.
Now on display at the Stone Circle Museum.

[Michael Tellinger @MichaelTelling2]

https://t.co/94aqtaM6yt

[Michael Tellinger @MichaelTelling2]

The human eye relies on three types of cone photoreceptors in your retina that are sensitive to red, green, and blue light. Every color we perceive is a mix of these three. And nature does it all by itself. No college degrees or skills training required.
Miracle or accident? 😊.

[Michael Tellinger @MichaelTelling2]

Women's Wellness Retreat
https://t.co/qt75nc8FsN

[Michael Tellinger @MichaelTelling2]

https://t.co/qMSn6SWn1W

[Michael Tellinger @MichaelTelling2]

https://t.co/qMSn6SWn1W

[Michael Tellinger @MichaelTelling2]

Join us.
https://t.co/PKyV6xAMOQ

[Michael Tellinger @MichaelTelling2]

Ramaphosa and his crooked ANC cronies will be remembered in the near future as the most corrupt government that has ever ruled any country. An unimaginable destruction force. Time to start rebuilding our awesome country.
https://t.co/GpY8t85PYz

[Conscious Caracal 🇿🇦 @ConCaracal]

@DailyInvestorSA Total mystery as to how South Africa fell so far behind...

[Michael Tellinger @MichaelTelling2]

The Rainbow Nation has been brought to its knees by a criminal and corrupt ANC government. It's up to the awesome Rainbow People to stand united, start rebuilding our country and start shining that light that gave us the name of the Rainbow Nation.
https://t.co/GpY8t85PYz

[Michael Tellinger @MichaelTelling2]

We can't beat the system by fighting it but we can create a new system that makes the existing slavery system obsolete.
The minority support (rule) principle does exactly that.
We stop prioritizing profit, and start prioritizing benefit to community.
https://t.co/GpY8t85PYz

[Michael Tellinger @MichaelTelling2]

We are waking up.
The medical tyranny of big pharma is crumbling.
Next step - 5 star clinics in all small towns to give real health support and provide the natural treatments that prevent disease, not hide the symptoms.
https://t.co/GpY8t85PYz

[Nicolas Hulscher, MPH @NicHulscher]

BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal

84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.

Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.

The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.

Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.

At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)

Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.

Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.

This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.

With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.

In the meantime, many cancer patients are exercising their right to try.

@twc_health @McCulloughFund @IIAR_Journals @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

[Michael Tellinger @MichaelTelling2]

Let food be our medicine.

[Michael Tellinger @MichaelTelling2]

yes- and that's what they've been doing for a long, long time. Only we, the people can stop them.

[Michael Tellinger @MichaelTelling2]

https://t.co/RKs5GnJJ5C